Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

ClinicalTrials.gov ID: NCT04819269

Public ClinicalTrials.gov record NCT04819269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will examine the efficacy and safety of tivanisiran sodium eye drops versus vehicle after a 2-week run-in phase when dosed once daily for 3 months in subjects with signs and symptoms of dry eye disease (DED) due to Sjögren's Syndrome.

Study identification

NCT ID
NCT04819269
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sylentis, S.A.
Industry
Enrollment
203 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2021 (Actual)
Primary completion
Dec 11, 2023 (Actual)
Completion
Dec 11, 2023 (Actual)
Last update posted
Feb 20, 2024

2021 – 2023

United States locations

U.S. sites
39
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Sylentis Investigative Site Birmingham Alabama 35294 —
Sylentis Investigative Site Dothan Alabama 36301 —
Sylentis Investigative Site Scottsdale Arizona 85254 —
Sylentis Investigative Site Garden Grove California 92843 —
Sylentis Investigative Site Glendale California 91204 —
Sylentis Investigative Site Los Angeles California 90013 —
Sylentis Investigative Site Newport Beach California 92663 —
Sylentis Investigative Site Rancho Cordova California 95670 —
Sylentis Investigative Site San Diego California 92122 —
Sylentis Investigative Site Torrance California 90505 —
Sylentis Investigative Site Aurora Colorado 80045 —
Sylentis Investigative Site Colorado Springs Colorado 80907 —
Sylentis Investigative Site Littleton Colorado 80120 —
Sylentis Investigative Site Jacksonville Florida 32256 —
Sylentis Investigative Site Largo Florida 33773 —
Sylentis Investigative Site Miami Florida 33136 —
Sylentis Investigative Site Ormond Beach Florida 32174 —
Sylentis Investigative Site Tampa Florida 33603 —
Sylentis Investigative Site Atlanta Georgia 30339 —
Sylentis Investigative Site Morrow Georgia 30260 —
Sylentis Investigative Site Carmel Indiana 46290 —
Sylentis Investigative Site Waltham Massachusetts 02451 —
Sylentis Investigative Site Ypsilanti Michigan 48197 —
Sylentis Investigative Site Kansas City Missouri 64111 —
Sylentis Investigative Site St Louis Missouri 63131 —
Sylentis Investigative Site Washington Missouri 63090 —
Sylentis Investigative Site Asheville North Carolina 28803 —
Sylentis Investigative Site High Point North Carolina 27262 —
Sylentis Investigative Site Fargo North Dakota 58103 —
Sylentis Investigative Site Cleveland Ohio 44115 —
Sylentis Investigative Site Columbus Ohio 43215 —
Sylentis Investigative Site Cranberry Township Pennsylvania 16066 —
Sylentis Investigative Site Rapid City South Dakota 57701 —
Sylentis Investigative Site Memphis Tennessee 38103 —
Sylentis Investigative Site Nashville Tennessee 37215 —
Sylentis Investigative Site El Paso Texas 79902 —
Sylentis Investigative Site Houston Texas 77030 —
Sylentis Investigative Site Houston Texas 77034 —
Sylentis Investigative Site Falls Church Virginia 22042 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04819269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04819269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →